_PNG.png)
Thomas C. Südhof
Nobel Prize in Physiology or Medicine 2013
Dept. of Molecular and Cellular Physiology, School of Medicine Stanford University, Howard Hughes Medical Institute, Stanford Institute of Medicine
Südhof studied medicine at RWTH Aachen University, Harvard University and then the University of Göttingen. At Göttingen Südhof she worked on his doctoral thesis, in which he described the structure and function of chromaffin cells. He completed his PhD at Harvard University under the tutelage of 1985 Nobel Prize winners in Medicine Michael Stuart Brown and Joseph Leonard Goldstein, whose work on the mechanics of cellular fluid transmission would be the starting point of his postdoctoral thesis.
In 2013, he was awarded the Nobel Prize in Medicine along with James E. Rothman and Randy Schekman for their studies on the functioning of cell vesicle trafficking.
Currently, one of his areas of research is the question of how synapses are formed in embryonic brain development and later during learning processes (synaptic plasticity) and how they are specified. Südhof also investigates the causes of neuronal diseases such as Alzheimer's, Parkinson's, schizophrenia, anxiety and autism and the effect of botulinum at the cellular and molecular level.
Christoph Borner
Institute of Molecular Medicine, University of Freiburg, Germany
He is Full Professor (C4/W3) of Molecular and Cellular Research, Institute of Molecular Medicine, Universität Freiburg, Germany. He is the director of the “International Master Program in Biomedical Sciences” (IMBS), a double degree master's degree between the UBA and the University of Freiburg (since 2017).
His research tries to elucidate the interactions between protein complexes responsible for cell survival or death through apoptosis. He is currently studying mechanisms of apoptosis induced by viruses or fungal toxins.
Pablo Power
Instituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina
Pablo Power is Biochemist, PhD from the University of Buenos Aires. He is Professor of Microbiology (FFyB-UBA) and Independent Researcher at CONICET. His expertise and projects include molecular, evolutive, biochemical and structural studies of β-lactamases from pathogens and environmental microorganisms, structure-activity relationship (SAR) studies aimed at the study of novel β-lactamase inhibitors, use of metagenomics approaches for accessing novel antimicrobial resistance genes from uncultured bacteria. ORCID: https://orcid.org/0000-0002-7051-9954.
Jürgen Rühe
Laboratory for Chemistry and Physics of Interfaces, Department of Microsystems Engineering, University of Freiburg
Since 2018 - Spokesperson of the DFG Cluster of Excellence “Living and Energy Autonomous Materials Systems” (livMatS)
Since 2018 - Director Freiburg Institute for Interactive Materials and Bioinspired Technologies (FIT), University of Freiburg
Since 1999 - Professor of “Chemistry and Physics of Interfaces”, IMTEK – Department of Microsystems Engineering, University of Freiburg
Prof. Rühe has published more than 400 papers, which have been cited about 17.000 times with an H-factor of 69, both according to Google scholar. More than 30 patent families have been awarded to him. He has supervised more than 100 PhD students.
ORCID-ID :0000-0002-2534-8228
Marcela Moretton
Department of Pharmaceutical Technology, Faculty of Pharmacy and Biochemistry (FFyB), University of Buenos Aires (UBA). Argentina Institute of Pharmaceutical Technology and Biopharmacy (InTecFyB), University of Buenos Aires. Argentina.
​Dr. Marcela A. Moretton is an Adjunct Professor at the Department of Pharmaceutical Technology (FFyB, UBA). Also she is a Researcher of the National Science Research Council (CONICET) and InTecFyB. She graduated in pharmacy at UBA (2007) and received her PhD from the UBA (2013) in Pharmaceutical Technology. In 2013–2015, she obtained a postdoctoral fellowship from CONICET at the Department of Pharmaceutical Technology (FFyB-UBA). She works on the development of polymeric nanomicelles, nanoparticles and nanopolymersomes as drug delivery systems. Her interests also include the synthesis of novel biomaterials focused on active drug targeting to optimize the pharmacotherapy in tuberculosis, pediatric HIV and cancer.
Natalia Magnani
Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica. Instituto de Bioquímica y Medicina Molecular Prof. Alberto Boveris (IBIMOL UBA-CONICET)
Dr. Magnani, studied Biological Sciences, followed by her PhD degree in biochemistry from the Pharmacy and Biochemistry Faculty at the University of Buenos Aires. Her doctoral research “Role of the redox metabolism involved in the lung damage mechanisms initiated by airborne particulate matter exposure” was conducted under the guidance of Dr. Evelson. Subsequently, she pursued postdoctoral studies at the Northwestern University in Chicago, working within the research laboratory of Dr. Szajder. Currently, Dr. Magnani holds the position of Associate Professor at the Department of General and Inorganic Chemistry within the Faculty of Pharmacy and Biochemistry, and Assistant researcher at CONICET at the Institute of Biochemistry and Molecular Medicine, Professor Alberto Boveris. Her present research project deals with the urban air impact over the lung injury resolution mechanisms.
Laura Caltana
Instituto de Biología Celular y Neurociencia "Prof E. De Robertis". (IBCN). Facultad de Medicina, Universidad de Buenos Aires.
Dr. Caltana studied Medicine in the University of Buenos Aires. She is a former student of the IMBS. Her PhD thesis was focused in the study of neuroprotective role of cannabinoid system in a model of cerebral ischemia. Dr. Caltana is a researcher from CONICET and her current research is focused on the study of the pathogenesis of depression and the implication of the cannabinoid system and treatment with Cannabis extract oils.
Feres Mocayar
LWL Klinik für Psychiatrie und Psychotherapie Rheine
Feres Mocayar Maron graduated with honors from the University Nacional de Cuyo in 2021, earning a degree in Medicine. During his medical studies, he also served as a teaching assistant in the field of Biological Chemistry, specifically in the course "From Molecules to Cells."
He held the position of President at the Scientific Society of Health Science Students (ACES UNCUYO). In 2019, he dedicated a year to research at the Cell and Molecular Neuroimmunology Laboratory, led by Dr. Thomas Blank, at the Uniklinik in Freiburg, Germany.
Currently, Feres works as a resident physician at the LWL Clinic for Psychiatry and Psychotherapy in Rheine, Germany.
Thomas Blank
Institute of Neuropathology, University Medical Center, Freiburg, Germany
Thomas Blank is currently a Group Leader at the Institute of Neuropathology within the University Medical Center in Freiburg, Germany. He completed his PhD in 1997 at the Max Planck Institute for Experimental Medicine, Department of Molecular Neuroendocrinology in Goettingen, Germany, where he initiated fundamental studies focusing on the molecular and electrophysiological mechanisms underpinning learning and memory. His research trajectory expanded through significant stays at the Scripps Research Institute in San Diego and the University Medical School in Honolulu, Hawaii from 2005 to 2009. Relocating to Freiburg in 2010, he undertook the role of heading the Cellular and Molecular Neuroimmunology Group, where his primary objectives involve uncovering new avenues for therapeutic interventions and identifying essential biomarkers. His research encompasses the intricate multi-mechanism pathways connecting the gut-brain and other gut-organ axes, all with potential implications for clinically significant outcomes.
Bruno Buccholz
Institute of Biochemistry and Molecular Medicine (IBIMOL-UBA-CONICET); Department of Anatomy, Faculty of Medicine, University of Buenos Aires.
After completing his medical degree (M.D.), Dr. Buchholz did his PhD and postdoctoral research at the Institute of Cardiovascular Pathophysiology (INFICA), Department of Pathology, Faculty of Medicine, University of Buenos Aires (UBA). Currently, he holds a position as an Associate Professor of Anatomy (Faculty of Medicine, UBA) and Researcher at CONICET (Institute of Biochemistry and Molecular Medicine). Over the past fifteen years, he has been studying morphological aspects of the cardiac neuraxis and pathophysiological mechanisms of cardiovascular autonomic regulation in ischemic heart disease.
Timoteo Marchini
Vascular Immunology Lab, Cardiology and Angiology Department, University Hospital Freiburg, Germany
Timoteo Marchini is a Biochemist. He got his M.Sc. degree in Biomedical Sciences (IMBS) and his Ph.D. in Biochemistry from the University of Buenos Aires, Argentina. He is now the Deputy Lab Head of the Vascular Immunology Lab at the Cardiology Department of the University Hospital Freiburg, Germany. His research focuses on (auto)immune and inflammatory mechanisms in atherosclerosis, myocardial infarction, and the metabolic syndrome.
Mariela Gironacci
Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Dpto. Química Biológica, IQUIFIB (UBA-CONICET)
Dr. Mariela Gironacci studied pharmacy at the University of Córdoba and got her PhD on the role of angiotensin-(1-7), a protective component of the renin-angiotensin system, on sympathetic neurotransmission in the lab of Prof. Clara Peña at the University of Buenos Aires. She is Associate Professor at the Biological Department, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, and Principal Investigator (CONICET). Her research is still focused on the protective axis of the renin-angiotensin system, specifically on Mas receptor, the receptor that mediates the protective responses elicited by angiotensin-(1-7), and how the biological actions coupled to this receptor activation are influenced by interaction with other receptors.
Federico Monczor
Laboratorio de Farmacología de Receptores, Instituto de Investigaciones Farmacológicas, UBA-CONICET.
Federico Monczor graduated in biochemistry from the Faculty of Pharmacy and Biochemistry at the University of Buenos Aires. During his Ph.D. studies, he was a CONICET fellow and simultaneously pursued a career in teaching. Currently, he holds a position of professor in the Physics Department and serves as the leader of the Receptor Pharmacology Laboratory at the Institute of Pharmacology Research. His research interests primarily focus on understanding the mechanisms of action of receptor ligands and the integration of extracellular signals within cells. At present, his work focuses on exploring the crosstalk between glucocorticoid and histaminergic receptors and its implications in anti-inflammatory therapeutic strategies.
Ralph Wäsch
University Medical Center, Dept. of Hematology, Oncology and Stem Cell Transplantation
Prof. Wäsch studied Medicine from 1988-1994 in Berlin and New York. His medical thesis with the topic chromosomal localization of a gene for HLA class II-deficient combined immunodeficiency was awarded with summa cum laude. During his residency in Internal Medicine at Freiburg University Medical he performed clinical and translational research in cellular therapy. From 1999-2002 he moved to New York to perform postdoctoral research at Rockefeller University investigating basic mechanisms of the eukaryotic cell cycle. His is board certified in Internal Medicine, Hematology and Oncology and Palliative Medicine. Since 2009 he is Professor of Medicine (apl) at Freiburg University Medical Center. He is head of the Medical Cell Therapy and Research Section at the Freiburg University Medical Center and attending physician in cellular therapy, acute leukemia and myeloma service.
Ignacio Mastroleo
Collaborative Research Institute Intelligent Oncology (CRIION), Freiburg, Germany, National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina
Dr. Ignacio Mastroleo has a broad background in philosophy, with specific training and expertise in research ethics, and more recently on the ethics of medical innovation and the use of unproven interventions outside clinical trials during public health emergencies. Since 2018, he has been the director of the Bioethics Module of the IMBS Master. From September 2019 to July 2024, he was a board member of the International Association of Bioethics (IAB). Since March 2020, Dr. Mastroleo has served as ad-honorem expert in the World Health Organization (WHO) Ethics and COVID-19 Workgroup and, currently, WHO COVID-19 Ethics & Governance Workgroup. He was the leading writer of the recently published WHO ethics guidelines on the emergency use of unproven interventions outside research. He has also been a close collaborator with PAHO, WHO Regional Office for the Americas, in several consultancy activities for the Latin American region. Currently, Dr. Mastroleo is leading the Philosophy Research Program of AI for Health at the Collaborative Research Institute Intelligent Oncology (CRIION) in Freiburg, Germany.
Alicia Beatriz Penissi
Instituto de Histología y Embriología (IHEM-CCT Mendoza.CONICET, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina
Doctora en Bioquímica, egresada de la Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis.
Especialista en Docencia Universitaria, egresada de la Facultad de Filosofía y Letras, Universidad Nacional de Cuyo.
Formación Posdoctoral en el Laboratorio de Biología Celular, Departamento de Farmacología, Facultad de Ciencias Biológicas, Universidad de Concepción (Chile) y en el Departamento de Fisiología y Farmacología, Facultad de Medicina, Universidad de Salamanca (España).
Investigadora Independiente, Carrera del Investigador Científico y Tecnológico del Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). Instituto de Histología y Embriología (IHEM-CCT Mendoza-CONICET), Facultad de Ciencias Médicas, Universidad Nacional de Cuyo. Mendoza, Argentina.
Directora del Laboratorio Inmunofarmacología de Mastocitos y Bioactividad de Productos Naturales (IHEM-CONICET).
Profesora Adjunta, efectiva por concurso, Área de Histología y Embriología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo. Mendoza, Argentina.
Directora de Investigación, Secretaría de Desarrollo Institucional, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo. Mendoza, Argentina.
Marisa Fernández
Instituto De Estudios De La Inmunidad Humoral Prof. Ricardo A. Margni, Oficina De Coordinacion Administrativa Houssay, Consejo Nacional De Investigaciones Cientificas Y Tecnicas
Dr. Marisa Fernández completed her undergraduate studies in Biochemistry at the University of Buenos Aires, School of Pharmacy and Biochemistry. Following that, she pursued a Ph.D. in Immunology at UBA, focusing on the study of staphylococcal enterotoxins and their interaction with T cell receptors and MHC class II molecules.
She also had the opportunity to conduct research at the Center for Advanced Research in Biotechnology at the University of Maryland. Currently, she serves as an Independent Researcher at CONICET (National Scientific and Technical Research Council) and holds a full professorship at the University of Buenos Aires.
Dr. Fernández leads a research group at the IDHEU (UAB-CONICET) Cátedra de Inmunología (FFyB-UBA). Her work contributes to the understanding of the immune response against staphylococcal enterotoxins.
Nahuel Rios Marziali
Visceral Surgery, Hospices Civils de Lyon, France
He studied National University of Cuyo. As part of his studies, he carried out several international exchanges, one of them with the University of Freiburg in Germany, where he carried out 5 months of research that culminated in a publication in a scientific journal. It is that work that will be presented at the congress.